Patents by Inventor Gregory A. Ordway

Gregory A. Ordway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters
    Patent number: 10974050
    Abstract: Multi-modal stimulation therapy may be utilized in which two or more stimulation therapies having different stimulation parameters may be delivered to a single patient. This can preferentially stimulate different nerve fiber types and drive different functional responses in the target organs. The stimulation parameters that may vary between the different stimulation therapies include, for example, pulse frequency, pulse width, pulse amplitude, and duty cycle.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: April 13, 2021
    Assignees: LivaNova USA, Inc., East Tennessee State University
    Inventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell, Gregory A. Ordway
  • IMPLANTABLE NEUROSTIMULATOR-IMPLEMENTED METHOD UTILIZING MULTI-MODAL STIMULATION PARAMETERS
    Publication number: 20180361158
    Abstract: Multi-modal stimulation therapy may be utilized in which two or more stimulation therapies having different stimulation parameters may be delivered to a single patient. This can preferentially stimulate different nerve fiber types and drive different functional responses in the target organs. The stimulation parameters that may vary between the different stimulation therapies include, for example, pulse frequency, pulse width, pulse amplitude, and duty cycle.
    Type: Application
    Filed: June 14, 2018
    Publication date: December 20, 2018
    Applicants: Cyberonics, Inc., East Tennessee State University
    Inventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell, Gregory A. Ordway
  • Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters
    Patent number: 9999773
    Abstract: Multi-modal stimulation therapy may be utilized in which two or more stimulation therapies having different stimulation parameters may be delivered to a single patient. This can preferentially stimulate different nerve fiber types and drive different functional responses in the target organs. The stimulation parameters that may vary between the different stimulation therapies include, for example, pulse frequency, pulse width, pulse amplitude, and duty cycle.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: June 19, 2018
    Assignees: Cyberonics, Inc., East Tennessee State University
    Inventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell, Gregory A. Ordway
  • PARP Inhibitors for the Treatment of Major Depressive Disorder and Related Conditions
    Publication number: 20180042919
    Abstract: Pharmaceutical formulations comprising an inhibitor of poly(ADP)-ribose) polymerase-1 (PARP1) and their use for the treatment of major depressive disorder and conditions that share at least one of the two major defining symptoms of major depressive disorder.
    Type: Application
    Filed: August 11, 2017
    Publication date: February 15, 2018
    Inventors: Gregory A. Ordway, Attila Szebeni, Russell Brown
  • IMPLANTABLE NEUROSTIMULATOR-IMPLEMENTED METHOD UTILIZING MULTI-MODAL STIMULATION PARAMETERS
    Publication number: 20150119956
    Abstract: Multi-modal stimulation therapy may be utilized in which two or more stimulation therapies having different stimulation parameters may be delivered to a single patient. This can preferentially stimulate different nerve fiber types and drive different functional responses in the target organs. The stimulation parameters that may vary between the different stimulation therapies include, for example, pulse frequency, pulse width, pulse amplitude, and duty cycle.
    Type: Application
    Filed: October 22, 2014
    Publication date: April 30, 2015
    Inventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell, Gregory A. Ordway